ISI Life Sciences Overview
- Year Founded
-
2011
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
ISI Life Sciences General Information
Description
Developer of a therapeutic product designed to focus on oncology and diagnostic imaging assets. The company's product is designed to identify residual cancer cells during tumor resection and thus lower the rate of repeat surgery due to insufficient tumor surgical margins, enabling medical researchers to lower the cost of treatment while improving patient outcomes.
Contact Information
Corporate Office
- 610 Newport Center Drive
- Suite 500
- Newport Beach, CA 92660
- United States
Corporate Office
- 610 Newport Center Drive
- Suite 500
- Newport Beach, CA 92660
- United States
ISI Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Apr-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 23-Apr-2013 | Completed | Generating Revenue |
ISI Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
ISI Life Sciences Patents
ISI Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200297765-A1 | Modified immune cells and uses thereof | Active | 07-Sep-2017 | ||
| US-11717540-B2 | Modified immune cells and uses thereof | Active | 07-Sep-2017 | ||
| US-20180113128-A1 | Detection of urinary tract infections | Inactive | 20-Oct-2016 | ||
| US-20190227066-A1 | Compositions and methods for detecting cancer cells in a tissue sample | Inactive | 22-Aug-2016 | ||
| EP-3500303-A1 | Compositions and methods for detecting cancer cells in a tissue sample | Inactive | 22-Aug-2016 | G01N33/574 |
ISI Life Sciences Acquisitions (1)
ISI Life Sciences’s most recent deal was a Merger/Acquisition with Indicator Systems International. The deal was made on 19-Dec-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Indicator Systems International | 19-Dec-2012 | Merger/Acquisition | Biotechnology |
ISI Life Sciences FAQs
-
When was ISI Life Sciences founded?
ISI Life Sciences was founded in 2011.
-
Where is ISI Life Sciences headquartered?
ISI Life Sciences is headquartered in Newport Beach, CA.
-
What industry is ISI Life Sciences in?
ISI Life Sciences’s primary industry is Diagnostic Equipment.
-
Is ISI Life Sciences a private or public company?
ISI Life Sciences is a Private company.
-
What is ISI Life Sciences’s current revenue?
The current revenue for ISI Life Sciences is .
-
How much funding has ISI Life Sciences raised over time?
ISI Life Sciences has raised $354K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
